4 S&P 500 Stocks Hit 52-Week Highs On Friday
In a quiet market, a few unrelated stocks are making new highs on very different fundamentals.
As of Friday, July 31, just 4 S&P 500 stocks are trading at their 52-week highs. This is a narrow list for a market where the S&P 500 returned only +0.2% over the last month. The largest company reaching a new high is Bristol-Myers Squibb (BMY), with a market value of about $133.1 billion.
The four names come from four different industries, from Pharmaceuticals to Oil & Gas Exploration & Production. With no clear sector theme, the central question is what these otherwise unrelated businesses have in common. The list below details the names and their recent performance.
Friday’s Full 52-Week-High List
The table below lists every stock at its 52-week high, largest first, with one-day, one-week, one-month, and one-year returns:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| BMY | $133.1 Bil | 0.7% | 5.2% | 17.0% | 48.9% |
| EOG | $79.1 Bil | 2.2% | 1.6% | 16.5% | 26.9% |
| EA | $52.5 Bil | 0.1% | 0.4% | 2.1% | 34.8% |
| DXCM | $32.1 Bil | 12.0% | 16.6% | 21.2% | -6.3% |
Is every new high built on the same foundation?
A look at the fundamentals reveals very different profiles. DexCom (DXCM) posted the strongest one-month run on the list, up 21.2%. That move comes alongside revenue growth of 15.5% over the last twelve months and an operating margin of 22.9%.
Contrast that with Electronic Arts (EA), which trades at 59.1 times trailing earnings. That valuation is paired with revenue growth of 0.9% over the last twelve months. Bristol-Myers Squibb (BMY) and EOG Resources (EOG) both trade at 14.4 times trailing earnings, despite different growth and margin profiles.
Is a stock at its high a reason to buy or a reason to pause?
A 52-week high is a sign of strength, and strong stocks often continue to perform. But a price is not a verdict on a business. It is simply what the market was willing to pay at a moment in time.
The disciplined approach is to treat the high as a prompt, not a conclusion. It is a reason to look again at the underlying company and ask whether its revenue growth and margins justify the market’s current valuation. The price is new, but the question is old: does the business earn the level?
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
New Highs Grow Positions Faster Than Plans Do
A new high is real progress, and it is also how winners grow into outsized positions. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.